These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 314662)
1. [Is there a correlation between sugar content, thrombocyte aggregating activity and molecular size of factor VIII?]. Furlan M; Perret BA; Beck EA Schweiz Med Wochenschr; 1979 Sep; 109(37):1369-70. PubMed ID: 314662 [TBL] [Abstract][Full Text] [Related]
2. Studies on factor VIII-related protein. IV. Interaction of galactose-specific lectins with human factor VIII/Von Willebrand factor. Furlan M; Perret BA; Beck EA Biochim Biophys Acta; 1980 Jun; 623(2):402-11. PubMed ID: 6772231 [TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of sugar composition of factor VIII/von Willebrand factor in von Willebrand's disease: analysis by crossed affinoimmunoelectrophoresis using lectin (ricinus communis agglutinin-120). Mikami S; Ueda M; Yasui M; Takahashi Y; Nishino M; Fukui H Thromb Haemost; 1983 Apr; 49(2):87-90. PubMed ID: 6408753 [TBL] [Abstract][Full Text] [Related]
4. Studies on factor VIII-related protein. III. Size distribution and carbohydrate content of human and bovine factor VIII. Furlan M; Perret BA; Beck EA Biochim Biophys Acta; 1979 Aug; 579(2):325-33. PubMed ID: 534647 [TBL] [Abstract][Full Text] [Related]
5. Von Willebrand activity of low molecular weight human Factor VIII increases by binding to gold granules. Furlan M; Perret BA; Beck EA Thromb Haemost; 1981 Jun; 45(3):242-6. PubMed ID: 6792738 [TBL] [Abstract][Full Text] [Related]
6. A critical evaluation of the available methods for the determination of factor VIII von Willebrand. Casonato A; Girolami A Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):670-84. PubMed ID: 2435633 [TBL] [Abstract][Full Text] [Related]
7. Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure. Switzer ME; McKee PA J Clin Invest; 1976 Apr; 57(4):925-37. PubMed ID: 1084890 [TBL] [Abstract][Full Text] [Related]
8. Carbohydrate of the factor VIII/von Willebrand factor in von Willebrand's disease. Zimmerman TS; Voss R; Edgington TS J Clin Invest; 1979 Nov; 64(5):1298-302. PubMed ID: 315413 [TBL] [Abstract][Full Text] [Related]
9. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin. Dejana E; Furlan M; Barbieri B; Donati MB; Beck EA Thromb Haemost; 1984 Aug; 52(1):57-9. PubMed ID: 6437011 [TBL] [Abstract][Full Text] [Related]
10. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content. Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944 [TBL] [Abstract][Full Text] [Related]
11. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor. Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469 [TBL] [Abstract][Full Text] [Related]
12. [Increased von Willebrand activity of low molecular-weight factor VIII following binding to gold granules]. Furlan M; Perret BA; Beck EA Schweiz Med Wochenschr; 1980 Oct; 110(40):1456-8. PubMed ID: 6792697 [TBL] [Abstract][Full Text] [Related]
13. Effect of carbohydrate modifications of factor VIII/von Willebrand factor on binding to platelets. Goudemand J; Mazurier C; Samor B; Bouquelet S; Montreuil J; Goudemand M Thromb Haemost; 1985 Jun; 53(3):390-5. PubMed ID: 2864750 [TBL] [Abstract][Full Text] [Related]
14. Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease. Sultan Y; Simeon J; Caen JP J Lab Clin Med; 1976 Feb; 87(2):185-94. PubMed ID: 1082003 [TBL] [Abstract][Full Text] [Related]
15. Effects of thrombin treatment of preparations of factor VIII and the Ca2+-dissociated small active fragment. Cooper HA; Reisner FF; Hall M; Wagner RH J Clin Invest; 1975 Sep; 56(3):751-60. PubMed ID: 1080490 [TBL] [Abstract][Full Text] [Related]
16. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat. Winocour PD; Lopes-Virella M; Laimins M; Colwell JA J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193 [TBL] [Abstract][Full Text] [Related]
17. Characterization of a form of bovine factor VIII which does not aggregate human platelets. Kirby EP Thromb Haemost; 1981 Aug; 46(2):479-84. PubMed ID: 6795738 [TBL] [Abstract][Full Text] [Related]
18. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers. Casonato A; Pontara E; Dannhäuser D; Bertomoro A; Sartori MT; Girolami A Haematologia (Budap); 1994; 26(2):97-109. PubMed ID: 7890268 [TBL] [Abstract][Full Text] [Related]
19. The interaction of bovine factor VIII with human platelets. Kirby EP; Mills DC J Clin Invest; 1975 Aug; 56(2):491-502. PubMed ID: 807600 [TBL] [Abstract][Full Text] [Related]
20. Bernard-Soulier syndrome: a new platelet glycoprotein abnormality. Its relationship with platelet adhesion to subendothelium and with the factor VIII von Willebrand protein. Caen JP; Nurden AT; Jeanneau C; Michel H; Tobelem G; Levy-Toledano S; Sultan Y; Valensi F; Bernard J J Lab Clin Med; 1976 Apr; 87(4):586-96. PubMed ID: 1083883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]